Table 3.
Model 1 | Model 2 | |||||
---|---|---|---|---|---|---|
RP (IC95%) | p Value | RP (IC95%) | p Value | |||
Excess body weight † | ||||||
Folate (μg/d) | ||||||
T1 < 407.95 | 1.0 | 1.0 | ||||
T2 407.95–511.12 | 0.75 (0.67–0.84) | <0.001 | 0.77 (0.69–0.87) | <0.001 | ||
T3 > 511.12 | 0.76 (0.68–0.85) | <0.001 | 0.79 (0.71–0.89) | <0.001 | ||
Vitamin B6 (mg/d) | ||||||
T1 < 1.50 | 1.0 | 1.0 | ||||
T2 1.50–1.79 | 0.94 (0.84–1.05) | 0.332 | 0.99 (0.89–1.12) | 0.999 | ||
T3 > 1.79 | 0.88 (0.78–0.98) | 0.032 | 0.91 (0.81–1.02) | 0.112 | ||
Vitamin B12 (μg/d) | ||||||
T1 < 3.16 | 1.0 | 1.0 | ||||
T2 3.16–4.50 | 0.98 (0.88–1.11) | 0.860 | 1.03 (0.91–1.16) | 0.570 | ||
T3 > 4.50 | 1.00 (0.90–1.13) | 0.878 | 1.05 (0.93–1.18) | 0.385 | ||
Obesity † | ||||||
Folate (μg/d) | ||||||
T1 < 407.95 | 1.0 | 1.0 | ||||
T2 407.95–511.12 | 0.57 (0.43–0.75) | <0.001 | 0.61 (0.46–0.81) | 0.001 | ||
T3 > 511.12 | 0.58 (0.45–0.76) | <0.001 | 0.60 (0.45–0.78) | <0.001 | ||
Vitamin B6 (mg/d) | ||||||
T1 <1.50 | 1.0 | 1.0 | ||||
T2 1.50–1.79 | 0.88 (0.67–1.16) | 0.382 | 1.07 (0.81–1.40) | 0.608 | ||
T3 >1.79 | 0.75 (0.57–0.99) | 0.043 | 0.86 (0.65–1.13) | 0.286 | ||
Vitamin B12 (μg/d) | ||||||
T1 <3.16 | 1.0 | 1.0 | ||||
T2 3.16–4.50 | 1.04 (0.78–1.38) | 0.761 | 1.25 (0.94–1.66) | 0.122 | ||
T3 > 4.50 | 1.00 (0.75–1.32) | 0.976 | 1.17 (0.88–1.55) | 0.261 |
* Excess body weight: BMI ≥ 25 kg/m2 (WHO, 1998), BMI ≥ 28 kg/m2 (OPAS, 2002) for adults and elderly respectively. ** Obesity: BMI ≥ 30 kg/m2 (WHO, 1998; OPAS, 2002). † Sample represents 1028 participants with excess body weight and 271 with obesity. Poisson regression Model 1: adjusted for age and sex. Poisson regression Model 2: adjusted for sex (female/male), age (years), alcohol consumption (yes/no), physical activity (yes/no), smoking (never smoked/former smoker/currently smoke), television hours per day (>1 h/ ≤1 h), use of vitamin supplement (yes/no), and daily caloric intake.